ERBB2 and breast cancer: Haghbin et al. found that the number of circulating PMPs was higher in patients with BC than in healthy controls, and the number of PMPs was significantly correlated with tissue biomarkers, such as oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (Her-2) [159].